Reaction Details Report a problem with these data
Target
Arginase-1
Ligand
BDBM438898
Substrate
n/a
Meas. Tech.
Inhibition of Arginase
IC50
625±n/a nM
Citation
 Van Zandt, M; Jagdmann, GE Arginase inhibitors as therapeutics US Patent  US11389464 Publication Date 7/19/2022 
Target
Name:
Arginase-1
Synonyms:
ARG1 | ARGI1_HUMAN | Liver-type arginase | Type I arginase
Type:
PROTEIN
Mol. Mass.:
34737.53
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978893
Residue:
322
Sequence:
MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK
  
Inhibitor
Name:
BDBM438898
Synonyms:
(1S,2S,4S)-1,4-diamino-2-(3-boronopropyl)cyclopentane- carboxylic acid | US10603330, Example 61 | US11389464, Example 61
Type:
Small organic molecule
Emp. Form.:
C9H19BN2O4
Mol. Mass.:
230.069
SMILES:
N[C@H]1C[C@H](CCCB(O)O)[C@@](N)(C1)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: